RB1 and prostate carcinoma: It has been shown that Rb deletion can promote angiogenesis, metastasis and neuroendocrine differentiation (NED), a process by which epithelial tumor cells acquire features of neuroendocrine cells, resulting in a more aggressive phenotype in human prostate cancer cells (34).